BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2025 5:57:55 AM | Browse: 277 | Download: 534
Publication Name World Journal of Transplantation
Manuscript ID 105649
Country United Kingdom
ISSN 2220-3230 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Beyond futility: The history and potential of liver transplantation in cholangiocarcinoma
Manuscript Source Invited Manuscript
All Author List Lynn Affarah, Sreelakshmi Kotha and Philip Berry
ORCID
Author(s) ORCID Number
Sreelakshmi Kotha http://orcid.org/0000-0003-3144-503X
Philip Berry http://orcid.org/0000-0003-0104-4737
Funding Agency and Grant Number
Corresponding Author Sreelakshmi Kotha, Department of Hepatology, Guy's and St Thomas' Hospital, Westminster Bridge road, London SE1 7JD, United Kingdom. sreelakshmi.kotha@gstt.nhs.uk
Key Words Cholangiocarcinoma; Extrahepatic cholangiocarcinoma; Intrahepatic cholangiocarcinoma; Primary sclerosing cholangitis; Liver transplantation
Core Tip Liver transplantation (LT) had previously been contraindicated in the treatment of cholangiocarcinoma (CCA). However, recent advances in both oncological treatment and patient-selection criteria have led to a paradigm shift, with various studies showing that patients with locally advanced CCA undergoing LT have promising outcomes. Numerous centers in North America and Europe have now adopted this as standard of care. Organ scarcity is a major factor to be considered. These complex patients are best managed by a multi-disciplinary team.
Publish Date 2025-11-19 05:57
Citation

Affarah L, Kotha S, Berry P. Beyond futility: The history and potential of liver transplantation in cholangiocarcinoma. World J Transplant 2025; 15(4): 105649

URL https://www.wjgnet.com/2220-3230/full/v15/i4/105649.htm
DOI https://dx.doi.org/10.5500/wjt.v15.i4.105649
Full Article (PDF) WJT-15-105649-with-cover.pdf